Literature DB >> 31144586

EXPRESS: Acute Vasoreactivity Testing in Pediatric Idiopathic Pulmonary Arterial Hypertension: an international Survey on Current Practice.

Lina Caicedo1, Rachel K Hopper2, Humberto Garcia3, David D Ivy4, Dora Haag5, Jeffrey Fineman6, Tlman Humpi, Omar Al-Tamimi7, Jeff Feinstein8, Rolf Mf Berger9, Erika Berman-Rosenzweig10, Tarek Kashour11, Gabriel Fernando Diaz12, Alberto Mendoza13, Prashant Bobhate14, Stephanie Handler15, Antonio Augusto Lopes16, Parag Barwad17, Manoj Kumar Rahit18, Usha Krishnan19, Ian Thomas Kassam Adatia20, Shahin Moledina21, Steven Abman22, Maria Jesus Del Cerro Marin23.   

Abstract

Entities:  

Year:  2019        PMID： 31144586     DOI： 10.1177/2045894019857533

Source DB:  PubMed          Journal:  Pulm Circ        ISSN： 2045-8932            Impact factor:   3.017


× No keyword cloud information.
  3 in total

1.  Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.

Authors:  Erika B Rosenzweig; Angela Bates; Mary P Mullen; Steven H Abman; Eric D Austin; Allen Everett; Jeffrey Fineman; Jeffery Feinstein; Rachel K Hopper; John P Kinsella; Usha S Krishnan; Minmin Lu; Kenneth D Mandl; J Usha Raj; Nidhy Varghese; Delphine Yung; Stephanie S Handler; Lynn A Sleeper
Journal:  Ann Am Thorac Soc       Date:  2022-06

2.  Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.

Authors:  Stephanie S Handler; Nidhy P Varghese; Erika B Rosenzweig; Delphine Yung; Usha Krishnan; Elise Whalen; Angela Bates; Catherine M Avitabile; Emma O Jackson; Russel Hirsch; Jeffrey Fineman; Steven H Abman
Journal:  Pulm Circ       Date:  2022-02-15       Impact factor: 2.886

3.  Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers.

Authors:  Hythem Nawaytou; Jeffrey R Fineman; Shahin Moledina; Dunbar Ivy; Steven H Abman; Maria J Del Cerro
Journal:  Pulm Circ       Date:  2021-02-09       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.